Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.41B.
ENTERPRISE VALUE (EV)
$1.41B
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Enterprise Value (EV)
$1.41B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | $1.41B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | $2.52B |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | $3.81B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | $1.67B |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | $3.11B |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | $1.27B |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | $773.18M |
| NRC Health (NRC)vs › | $459.30M | $546.00M |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | $380.37M |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | $40.01M |
Market Cap
$2.13B
Total Debt
$18.66M
Cash
$743.29M
Enterprise Value
$1.41B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
